CNTA
Centessa Pharmaceuticals-adr
$10.78
Earnings Summary
Revenue | $6.91Mn |
Net Profits | $-37.16Mn |
Net Profit Margins | -537.53% |
Highlights
Centessa Pharmaceuticals-adr’s revenue jumped +Inf% since last year same period to $6.91Mn in the Q4 2023. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated +Inf% jump in its revenue since last 3-months.
Centessa Pharmaceuticals-adr’s net profit jumped 13.93% since last year same period to $-37.16Mn in the Q4 2023. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated 3.86% jump in its net profits since last 3-months.
Centessa Pharmaceuticals-adr’s net profit margin jumped NaN% since last year same period to -537.53% in the Q4 2023. On a quarterly growth basis, Centessa Pharmaceuticals-adr has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Centessa Pharmaceuticals-adr post its latest quarter earnings
EPS Estimate Current Quarter | -0.44 |
EPS Estimate Current Year | -0.44 |
Highlights
Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current quarter stand at -0.44 - a 8.33% jump from last quarter’s estimates.
Centessa Pharmaceuticals-adr’s earning per share (EPS) estimates for the current year stand at -0.44.
Key Ratios
Key ratios of the Centessa Pharmaceuticals-adr post its Q1 2024 earnings
Earning Per Share (EPS) | 0 |
Highlights
Centessa Pharmaceuticals-adr’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2024. This indicates that the Centessa Pharmaceuticals-adr has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-13 | -0.44 | 0 | 100% |
₹0 US Stocks a/c Opening Fee